A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Medical associations sue U.S. health leaders over COVID-19 vaccine restrictions, citing concerns about public health, vaccine ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

Health ministry has issued statement highlighting that extensive studies by ICMR and AIIMS, New Delhi have established there ...

While midazolam is the only sedative labeled for continuous use during mechanical ventilation in pediatric ICU patients, ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

Kennedy Jr. appeared on the latest episode of Tucker Carlson’s podcast on Monday and it’s filled with the ramblings of a man ...

Single doses of 150 milligrams (mg), 300 mg, and 450 mg provided 58%, 61%, and 76% protection from symptomatic flu, ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.